Home
Tangen Biosciences

Tangen Biosciences Market Share Analysis for July 2026

Industry: N/A

Domaintangenbiosciences.com

Year Founded--

Employees1001 - 5000

Annual Revenue$5M - $10M

Tangen Biosciences

Tangen Biosciences (including company regionals)

tangenbiosciences.com

See more website traffic and engagement information

Tangen Biosciences Revenue up to July 2026 is 5M - 10M

revenue generated by Tangen Biosciences top domains

Tangen Biosciences top domains revenue over 3 years

Revenue for Tangen Biosciences top domains

tangenbiosciences.com5M - 10M

See more with Sales Intelligence

Total visits to Tangen Biosciences's top domains

Understand Tangen Biosciences market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Tangen Biosciences's top domains

Analyze Tangen Biosciences engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Tangen Biosciences's top domains

See how Tangen Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Tangen Biosciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Tangen Biosciences

These are the website technologies, by industry, used by Tangen Biosciences top domains

Advertising (3)

Google Adsense

Conversion & Analytics (3)

Google Analytics

Widget (3)

Twemoji

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from Tangen Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTangenbiosciences received financing of $12.2M in Series B on Jul 1st '20.In July, Tangen closed $12.2 million in Series B financing, which was used to scale up the manufacturing capacity for Tangen’s COVID-19 test.

NewsConnecticut Innovations Inc invests into Tangenbiosciences $12.2M.Tangen Biosciences, Inc., a molecular diagnostic company located in Branford, Connecticut, announced that it has closed a $12.2 million Series B Preferred Stock financing with participation of current and new investors, including Connecticut Innovations, VC23, Leading Edge Ventures, and Parvizi Surgical.